Abiraterone Acetate

Abiraterone Acetate is a prescription medication that belongs to a class of drugs known as cytochrome P450 17A1 inhibitors. It is primarily used for the treatment of metastatic castration-resistant prostate cancer, which is a form of advanced prostate cancer that has not responded to hormone therapy.
Abiraterone Acetate works by inhibiting the production of androgens, which are male sex hormones that can stimulate the growth of prostate cancer cells. By blocking the enzyme responsible for androgen production, the medication helps to slow down the progression of the disease and prolong the survival of patients.
The medication is typically used in combination with another drug called prednisone or prednisolone, which helps to manage the side effects of Abiraterone Acetate. This combination therapy has been shown to be more effective than traditional hormone therapies in improving patient outcomes.
Abiraterone Acetate is usually prescribed for patients whose prostate cancer has spread to other parts of the body and has become resistant to other treatments, such as hormone therapy and chemotherapy. This medication should only be taken under the supervision of a healthcare professional, as it may cause serious side effects, including high blood pressure, heart problems, and liver issues.